Skin Diseases, Bacterial D017192

Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Skin Diseases, Bacterial

Diseases [C] » Infections [C01] » Skin Diseases, Infectious » Skin Diseases, Bacterial

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Infectious » Skin Diseases, Bacterial

Description

Skin diseases caused by bacteria.   MeSH

Hierarchy View

Subtype Terms (16)

Actinomycosis, Cervicofacial
 

Angiomatosis, Bacillary
 

Digital Dermatitis
7 drugs (4 approved, 3 experimental)

Ecthyma
 

Erysipelas
4 drugs (2 approved, 2 experimental)

Erythema Chronicum Migrans
4 approved drugs

Erythrasma
1 approved drug

Granuloma Inguinale
2 approved drugs

Hidradenitis Suppurativa
57 drugs (31 approved, 26 experimental)

Mycetoma
2 experimental drugs

Pinta
 

Rhinoscleroma
3 approved drugs

Staphylococcal Skin Infections
35 drugs (27 approved, 8 experimental)

Syphilis, Cutaneous
 

Tuberculosis, Cutaneous
 

Yaws
6 approved drugs


Phase 1 Indicated Drugs (2)

Other Experimental Indicated Drugs (3)


Organization Involved with Phase 4 Indications (4)

Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.